
FDA Panel Vote Ignites Controversy Over Unproven 'Wolverine' Peptides
A recent FDA advisory panel vote recommended loosening restrictions on six experimental peptides, including BPC-157 and TB-500, despite significant safety concerns. This move follows a surge in popularity driven by influencers and political figures, though the substances remain unproven in human clinical trials and are banned in professional sports.










